21 Feb 2024

United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR) announced today the commencement of litigation with the United States Food and Drug Administration...

Download pdf

14 Feb 2024

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its fourth quarter and full year 2023 financial results before...

Download pdf

29 Dec 2023

United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Dr. Martine Rothblatt, Chairperson and Chief...

Download pdf

13 Dec 2023

United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. & EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today that United...

Download pdf

12 Dec 2023

United Therapeutics and Miromatrix Medical Announce Successful Tender Offer

Download pdf

07 Dec 2023

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics (Nasdaq: UTHR), a public benefit corporation, today announced that the company has been named on Newsweek’s list of America’s...

Download pdf

01 Nov 2023

United Therapeutics Corporation Reports Third Quarter 2023 Financial Results

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September...

Download pdf

31 Oct 2023

United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis

Up to 60,000 patients in the United States may have PPF, with only one approved therapy availableSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a...

Download pdf

31 Oct 2023

United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.,--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice President...

Download pdf

30 Oct 2023

United Therapeutics to Acquire Miromatrix Medical

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. & EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced...

Download pdf

25 Oct 2023

United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its third quarter 2023 financial results before the market...

Download pdf

22 Sep 2023

United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs

Second UHeart™ recipient recovering after a successful transplantUThymoKidney™ demonstrates normal function during a 61-day studyHuman xenotransplant clinical studies could begin in 2025SILVER SPRING, Md. & RESEARCH...

Download pdf